Leukemia Clinical Trials & Research for Children

Clinical trials have formed the foundation of virtually every advance made in cancer care. Trials can offer hope when standard therapies are no longer effective. MSK Kids offers a range of clinical trials assessing investigational approaches for children with leukemia. We have trials for cancer that has continued growing or has come back after treatment. These include studies assessing immunotherapies. These treatments boost the power of the immune system to find and kill cancer cells. We also study new drugs and stem cell transplantation techniques.

Your child’s care team will let you know if your child can participate in a clinical trial. The decision to enroll is entirely voluntary. The study team will explain the benefits and risks of the study to you so you can make an informed decision.

and/or
22 Clinical Trials found
In this study, researchers are assessing a new way to determine the best dosing of fludarabine. The people in this study are children and young adults getting CAR T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL). Their cancer has come back or keeps growing despite treatment. They will be getting a CAR T-cell therapy called tisagenlecleucel (Kymriah).
This study aims to obtain a better understanding of the genetic causes of Hodgkin's disease (a kind of lymphoma) and non-Hodgkin's lymphoma, as well as multiple myeloma, leukemia, and related diseases. Together these diseases are referred to as "lymphoproliferative disorders."